Literature DB >> 10699992

Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6).

J C Machado1, A M Nogueira, F Carneiro, C A Reis, M Sobrinho-Simões.   

Abstract

The expression of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6) has previously been described in gastric polyps. In the present study, the expression profile of these trefoil peptides and mucins was characterized in 96 gastric carcinomas, in an attempt to further the understanding of the histogenesis and cell differentiation of gastric carcinoma. Taking together the co-expression of trefoil peptides and mucins, three phenotypes were defined: complete gastric, incomplete gastric, and non-gastric phenotype. Gastric differentiation (complete and incomplete) was observed in 30 out of 33 (90.9%) diffuse carcinomas and in 38 out of 53 (71.7%) intestinal carcinomas. Non-gastric differentiation was observed in only three (9.1%) diffuse carcinomas and in 15 (28.3%) intestinal carcinomas. The phenotypes observed in intestinal carcinomas were similar to those previously observed in adenomatous polyps, whereas most diffuse carcinomas mimicked the phenotype of hyperplastic polyps. The percentage of cases displaying a non-gastric phenotype was higher, though not significantly, in tumours that had invaded the gastric wall than in T1 tumours, regardless of histotype. It is concluded that gastric-type differentiation is retained in the majority of gastric carcinomas, being more prominent in diffuse than in intestinal carcinomas, and in early than in advanced carcinomas. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699992     DOI: 10.1002/(SICI)1096-9896(200003)190:4<437::AID-PATH547>3.0.CO;2-1

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  32 in total

1.  Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Rita Rani Barua; Hiroshi Uozaki; Ja-Mun Chong; Tetsuo Ushiku; Rumi Hino; Moon-Sung Chang; Hideo Nagai; Masashi Fukayama
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  Relationships between mucinous gastric carcinoma, MUC2 expression and survival.

Authors:  Emmanuelle Leteurtre; Farid Zerimech; Guillaume Piessen; Agnes Wacrenier; Xavier Leroy; Marie-Christine Copin; Christophe Mariette; Jean-Pierre Aubert; Nicole Porchet; Marie-Pierre Buisine
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.

Authors:  Kimiyasu Yamazaki; Yusuke Tajima; Reiko Makino; Nobukazu Nishino; Shigeo Aoki; Masanori Kato; Masaaki Sakamoto; Koji Morohara; Tsutomu Kaetsu; Mitsuo Kusano
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness.

Authors:  Pedro Valente; Mónica Garrido; Irene Gullo; Helena Baldaia; Margarida Marques; Francisco Baldaque-Silva; Joanne Lopes; Fátima Carneiro
Journal:  Gastric Cancer       Date:  2014-08-22       Impact factor: 7.370

5.  Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.

Authors:  Satoshi Ikarashi; Ken Nishikura; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Gastric Cancer       Date:  2012-07-25       Impact factor: 7.370

6.  The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.

Authors:  Fulya Oz Puyan; Nuray Can; Filiz Ozyilmaz; Ufuk Usta; Necdet Sut; Ebru Tastekin; Semsi Altaner
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-10       Impact factor: 4.553

7.  The contribution of cell phenotype to the behavior of gastric cancer.

Authors:  Enrico Solcia; Catherine Klersy; Alessandro Vanoli; Federica Grillo; Rachele Manca; Francesca Tava; Ombretta Luinetti; Roberto Fiocca
Journal:  Gastric Cancer       Date:  2013-01-18       Impact factor: 7.370

8.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

9.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Authors:  Yesim Gürbüz; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

10.  Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation.

Authors:  H H-X Xia; Y Yang; S K Lam; W M Wong; S Y Leung; S T Yuen; G Elia; N A Wright; B C-Y Wong
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.